Global Peripherally Inserted Central Catheter Market Size study & Forecast, by Product Type (Single Lumen, Double Lumen, Multi Lumen), by End user (Hospitals & Clinics, Ambulatory Surgical Centers, Catheterization Laboratories) and Regional Analysis, 2023

Global Peripherally Inserted Central Catheter Market Size study & Forecast, by Product Type (Single Lumen, Double Lumen, Multi Lumen), by End user (Hospitals & Clinics, Ambulatory Surgical Centers, Catheterization Laboratories) and Regional Analysis, 2023-2030

Global Peripherally Inserted Central Catheter Market is valued at approximately USD xx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx% during the forecast period 2023-2030. Peripherally Inserted Central Catheter is a long, thin, flexible tube that is inserted into a peripheral vein, typically in the arm, and advanced until the tip reaches a large central vein near the heart. This type of catheter is often used for the administration of medications, fluids, and nutrients, as well as for drawing blood for testing. The Peripherally Inserted Central Catheter Market is expanding because of factors such as the rising number of cases related to cancer and the growing prevalence of chronic kidney disease. As a result, the demand for Peripherally Inserted Central Catheter has progressively increased in the international market during the forecast period 2023-2030.

Cancer patients need frequent blood draws for monitoring purposes and receive various medications intravenously. Peripherally Inserted Central Catheter line allows healthcare providers to access the patient's bloodstream easily without the need for repeated needle sticks. According to Global Cancer Observatory, the global number of nervous system cancer cases across the world accounts for 308 thousand in 2020 and projected to reach up to 372 thousand by the year 2030. Another important factor that drives the Peripherally Inserted Central Catheter Market is the increasing prevalence of chronic kidney disease. Patients with chronic kidney disease often have impaired fluid balance, and careful fluid management is crucial. Peripherally Inserted Central Catheters are commonly used to administer fluids, medications, and nutrition. Healthcare providers need to be cautious about fluid overload, especially in patients with compromised kidney function. In addition, as per the Centres for Disease Control and Prevention reported that 37 million Americans, or more than 1 in 7 persons, had chronic kidney disease in 2021, furthermore, as per a report by the national health portal of the Indian Government in July 2022, the prevalence of End-Stage Renal Disease (ESRD) in India is leading to a significant rise in the number of new patients, estimated at approximately 220 thousand cases each year. Moreover, the rising adoption of central venous access devices and surging demand for antimicrobial coated catheters are anticipated to create lucrative growth opportunities for the market over the forecast period. However, stringent guidelines and the high cost associated with peripherally inserted central catheters are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Peripherally Inserted Central Catheter Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing adopting of advanced medical devices and growing healthcare expenditure in the region. Growing healthcare expenditure often leads to a greater emphasis on achieving positive patient outcomes and cost-effectiveness. Healthcare providers carefully evaluate the benefits of using peripherally inserted central catheters in different clinical scenarios, considering factors such as patient satisfaction, complication rates, and overall cost-effectiveness. The region’s dominant performance is anticipated to propel the overall demand for Peripherally Inserted Central Catheter. Furthermore, Asia Pacific is expected to grow fastest over the forecast period, owing to factors such as governments allocating more funds to upgrade healthcare facilities in the region. Upgraded healthcare facilities focus on implementing robust infection control measures. In the case of peripherally implanted central catheters, this could entail using improved catheter materials, adhering to sterile insertion protocols, and monitoring for infection. As a result , enhanced infection management can lead to better patient outcomes.

Major market player included in this report are:
AngioDynamics Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Teleflex Incorporated
Argon Medical Devices, Inc.
Cook Medical Inc.
ICU Medical, Inc.
Medical Components, Inc.
Access Vascular Inc.
Vygon SA

Recent Developments in the Market:
 In November 2023, Becton, Dickinson and Company, a prominent global medical technology firm, introduced an innovative ultrasound system. This technique is designed to increase clinician efficiency when inserting peripherally inserted central catheters (PICCs), central venous catheters, IV lines, and other vascular access devices.

Global Peripherally Inserted Central Catheter Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product Type, End user, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type
Single Lumen
Double Lumen
Multi Lumen

By End user
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.